The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Allopurinol Teva 300 mg tablets

Teva Pharma B.V.PA0749/099/003

Main Information

Trade NameAllopurinol Teva 300 mg tablets
Active SubstancesAllopurinol
Dosage FormTablet
Licence HolderTeva Pharma B.V.
Licence NumberPA0749/099/003

Group Information

ATC CodeM04AA Preparations inhibiting uric acid production
M04AA01 allopurinol


License statusAuthorised
Licence Issued10/09/2010
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back